Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015 ; volume:17 ; number:1 ; day:3 ; month:5 ; year:2017 ; pages:1-11 ; date:12.2017
BMC infectious diseases ; 17, Heft 1 (3.5.2017), 1-11, 12.2017
- Schlagwort
-
Allergie
Immunkrankheit
- Urheber
-
Bulage, Lilian
- Beteiligte Personen und Organisationen
-
Ssewanyana, Isaac
Nankabirwa, Victoria
Nsubuga, Fred
Kihembo, Christine
Pande, Gerald
Ario, Alex R.
Matovu, Joseph KB
Wanyenze, Rhoda K.
Kiyaga, Charles
SpringerLink (Online service)
- DOI
-
10.1186/s12879-017-2428-3
- URN
-
urn:nbn:de:1111-201705141325
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bulage, Lilian
- Ssewanyana, Isaac
- Nankabirwa, Victoria
- Nsubuga, Fred
- Kihembo, Christine
- Pande, Gerald
- Ario, Alex R.
- Matovu, Joseph KB
- Wanyenze, Rhoda K.
- Kiyaga, Charles
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients